The development of vaccines: how the past led to the future (Q45197725)

10 December 2017

1 reference

title

The development of vaccines: how the past led to the future (English)

1 reference

10 December 2017

1

Stanley A Plotkin

1 reference

10 December 2017

Susan L Plotkin

2

1 reference

PubMed ID

21963800

10 December 2017

language of work or name

English

0 references

publication date

3 October 2011

1 reference

Nature Reviews Microbiology

10 December 2017

1 reference

10 December 2017

9

1 reference

10 December 2017

889-893

1 reference

10 December 2017

12

1 reference

https://scigraph.springernature.com/pub.10.1038/nrmicro2668

10 December 2017

0 references

cites work

Systems biology of vaccination for seasonal influenza in humans

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2668

Immunological mechanisms of vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2668

Vaccines: the Fourth Century

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2668

Development of Smallpox Vaccine in England in the Eighteenth and Nineteenth Centuries

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2668

Poxvirus genomes: a phylogenetic analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2668

21 January 2018

Genome of horsepox virus

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2668

The use of yellow fever virus modified by in vitro cultivation for human immunization

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2668

A Virus Obtained from Influenza Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2668

Development and characterization of cold-adapted viruses for use as live virus vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2668

Cultivation of the Lansing Strain of Poliomyelitis Virus in Cultures of Various Human Embryonic Tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2668

Studies on variants of poliomyelitis virus. I. Experimental segregation and properties of avirulent variants of three immunologic types

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2668

Studies on an attenuated measles-virus vaccine. VIII. General summary and evaluation of the results of vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2668

Live, attenuated mumps-virus vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2668

Isolation and Characterization of Gal E Mutant Ty 21a of Salmonella typhi: A Candidate Strain for a Live, Oral Typhoid Vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2668

CHEMO-IMMUNOLOGICAL STUDIES ON CONJUGATED CARBOHYDRATE-PROTEINS : V. THE IMMUNOLOGICAL SPECIFITY OF AN ANTIGEN PREPARED BY COMBINING THE CAPSULAR POLYSACCHARIDE OF TYPE III PNEUMOCOCCUS WITH FOREIGN PROTEIN.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2668

Interim Report of a Controlled Field Trial of Immunization with Capsular Polysaccharides of Haemophilus influenzae Type band Group C Neisseria meningitidis in Mecklenburg County, North Carolina (March 1974-March 1976)

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2668

Human immunity to the meningococcus. 3. Preparation and immunochemical properties of the group A, group B, and group C meningococcal polysaccharides

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2668

Preparation, characterization, and immunogenicity of Haemophilus influenzae type b polysaccharide-protein conjugates

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2668

Pneumococcal conjugate vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2668

Reexamination of the protective role of the capsular polysaccharide (Vi antigen) of Salmonella typhi

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2668

Human hepatitis B vaccine from recombinant yeast

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2668

Expression of vaccinia recombinant HPV 16 L1 and L2 ORF proteins in epithelial cells is sufficient for assembly of HPV virion-like particles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2668

Papillomavirus L1 major capsid protein self-assembles into virus-like particles that are highly immunogenic

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2668

A vaccine consisting of recombinant Borrelia burgdorferi outer-surface protein A to prevent Lyme disease. Recombinant Outer-Surface Protein A Lyme Disease Vaccine Study Consortium.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2668

Vaccination against Lyme disease with recombinant Borrelia burgdorferi outer-surface lipoprotein A with adjuvant. Lyme Disease Vaccine Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2668

The new pentavalent rotavirus vaccine composed of bovine (strain WC3) -human rotavirus reassortants

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2668

Efficacy of live, attenuated, human rotavirus vaccine 89-12 in infants: a randomised placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2668

A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2668

Correlates of protection induced by vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2668

A randomised, double-blind, controlled trial of the immunogenicity and tolerability of a meningococcal group C conjugate vaccine in young British infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2668

Vaccine discovery and translation of new vaccine technology

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2668

Formaldehyde treatment and safety testing of experimental poliomyelitis vaccines

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2668

Rubella vaccination. A review of practical experience

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2668

An inactivated hepatitis A viral vaccine of cell culture origin

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2668

Biotechnology: Cohen-Boyer patent finally confirmed.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2668

Development and function of the immunoglobulin producing system. I. Effect of bursectomy at different stages of development on germinal centers, plasma cells, immunoglobulins and antibody production

31 March 2020

1 reference

12 December 2020

Immune responses in human volunteers upon oral administration of a rodent-adapted strain of poliomyelitis virus

1 reference

12 December 2020

Development and clinical trials of the new human rabies vaccine of tissue culture (human diploid cell) origin

1 reference

12 December 2020

Development of a live attenuated varicella vaccine

1 reference

12 December 2020

[Pasteur and fowl cholera: critical review of a historical account].

1 reference

12 December 2020

Prevention of pneumococcal pneumonia by vaccination

1 reference

12 December 2020

Role of antibody to leukocytosis-promoting factor hemagglutinin and to filamentous hemagglutinin in immunity to pertussis.

1 reference

12 December 2020

An immunological rationale for vaccines

1 reference

12 December 2020

A scientific odyssey: unravelling the secrets of the thymus

1 reference

12 December 2020

Studies on Vi antigen. VI. Immunization of human beings with purified Vi antigen

1 reference

12 December 2020

Attenuation of RA 27/3 Rubella Virus in WI-38 Human Diploid Cells

1 reference

12 December 2020

Evaluation of Red Cross gamma globulin as a prophylactic agent for poliomyelitis. IV. Final report of results based on clinical diagnoses

1 reference

12 December 2020

Experimental live attenuated rubella virus vaccine. Clinical evaluation of Cendehill strain

1 reference

12 December 2020

Identifiers

DOI

10.1038/NRMICRO2668

1 reference

PubMed ID

21963800

Dimensions Publication ID

10 December 2017

0 references

1 reference

PubMed ID

21963800